Profile
| Metric | Value |
|---|---|
| Full Name | Propanc Biopharma, Inc. |
| Ticker | NASDAQ: PPCB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Australia |
| IPO | |
| Indexes | Not included |
| Website | propanc.com |
| Employees | 1 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.27 | |
| Price, 1D Change | -1.77% | |
| $4M | ||
| - | ||
| - | ||
| -8,577.39 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$14.85 | ||
| EPS, 1Y Change | -62,554.01% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:60000 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$14.85 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $0.27 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
Revenue
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.27 | |
| $3.08 | ||
| SMA 200 vs Price | +1,057.29% | |
| $0.67 | ||
| SMA 50 vs Price | +152.97% | |
| -8,577.39 | ||
| $0.06 | ||
| 13.82 | ||
| 77.65% | ||
| 6.27% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$14.85 | ||
| -$20.20K | ||
| - | ||
| -$57.28M | ||
| - | ||
| -$58.92M | ||
| - | ||
| -$57.26M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.12 | ||
| 1.50 | ||
| 1.50 | ||
| - | ||
| - | ||
| -18.04 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.25 | ||
| -0.06 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $13.91M | ||
| $12.10K | ||
| $19.63M | ||
| $8.35M | ||
| $5.73M | ||
| $5.58M | ||
| $1.73M | ||
| $1.58M | ||
| $1.25M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $58.92M | ||
| $57.26M | ||
| $20.20K | ||
| $0.00 | ||
| $20.20K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$405.20K | ||
| $0.00 | ||
| $490.80K | ||
| $0.00 | ||
| -$405.20K |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| No data | N/A | N/A |
Analyst sentiment
Institutional ownership
Screeners with PPCB
FAQ
What is the ticker symbol for Propanc Biopharma, Inc.?
The ticker symbol for Propanc Biopharma, Inc. is NASDAQ:PPCB
Does Propanc Biopharma, Inc. pay dividends?
No, Propanc Biopharma, Inc. does not pay dividends
What sector is Propanc Biopharma, Inc. in?
Propanc Biopharma, Inc. is in the Healthcare sector
What industry is Propanc Biopharma, Inc. in?
Propanc Biopharma, Inc. is in the Biotechnology industry
What country is Propanc Biopharma, Inc. based in?
Propanc Biopharma, Inc. is headquartered in Australia
When did Propanc Biopharma, Inc. go public?
Propanc Biopharma, Inc. initial public offering (IPO) was on November 12, 2012
Is Propanc Biopharma, Inc. in the S&P 500?
No, Propanc Biopharma, Inc. is not included in the S&P 500 index
Is Propanc Biopharma, Inc. in the NASDAQ 100?
No, Propanc Biopharma, Inc. is not included in the NASDAQ 100 index
Is Propanc Biopharma, Inc. in the Dow Jones?
No, Propanc Biopharma, Inc. is not included in the Dow Jones index
When does Propanc Biopharma, Inc. report earnings?
The date for Propanc Biopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- PPCB Official Website www.propanc.com
- PPCB Profile on Yahoo Finance finance.yahoo.com/quote/PPCB
- PPCB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ppcb